Literature DB >> 28911923

Secondary data sources for health services research in urologic oncology.

Alexander P Cole1, David F Friedlander1, Quoc-Dien Trinh2.   

Abstract

BACKGROUND: Though secondary data analyses of large datasets may reduce logistical and financial barriers required to perform significant and innovative work, such research requires specialized skills in data handling and statistical techniques as well as thorough and detailed knowledge of the data sources being used.
OBJECTIVES: To provide an overview of several common types of secondary data, focusing on strengths, weaknesses and examples of how these data may be used for health services research.
RESULTS: Secondary data comprise a broad and heterogeneous category. This review covers several large categories of such data with examples of their use and discussions about their strengths and weaknesses. Sources include administrative data, claims-based datasets, electronic health records health surveys, patient or disease or both registries, quality improvement initiatives, as well as data from existing trials. Linkages of different types of data may expand the scope of questions answerable using secondary data analysis. Specific strengths and weaknesses of each type of dataset are discussed along with examples from the recent urologic literature.
CONCLUSIONS: Choice of the appropriate data source should be tailored to the specific research question as well as the research resources and expertise available. Appropriate decisions about which data to use are the foundation for valid, high-impact research using secondary data.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Claims-based research; Comparative effectiveness research; Health services research; Research methods; SEER; Secondary data; Urologic oncology

Mesh:

Year:  2017        PMID: 28911923     DOI: 10.1016/j.urolonc.2017.08.008

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  10 in total

1.  Routinely collected data for population-based outcomes research.

Authors:  Blayne Welk
Journal:  Can Urol Assoc J       Date:  2019-07-23       Impact factor: 1.862

2.  Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era.

Authors:  Sean A Fletcher; Sabrina S Harmouch; Marieke J Krimphove; Alexander P Cole; Sebastian Berg; Philipp Gild; Mark A Preston; Guru P Sonpavde; Adam S Kibel; Maxine Sun; Toni K Choueiri; Quoc-Dien Trinh
Journal:  World J Urol       Date:  2018-06-14       Impact factor: 4.226

3.  The relationship between hospital volume and outcomes of radical prostatectomy: a new perspective on an old story.

Authors:  Marco Paciotti; Vittorio Fasulo; Giovanni Lughezzani
Journal:  Gland Surg       Date:  2020-08

4.  Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care.

Authors:  Joshua Sterling; Zorimar Rivera-Núñez; Hiren V Patel; Nicholas J Farber; Sinae Kim; Kushan D Radadia; Parth K Modi; Sharad Goyal; Rahul Parikh; Robert E Weiss; Isaac Y Kim; Sammy E Elsamra; Thomas L Jang; Eric A Singer
Journal:  Clin Genitourin Cancer       Date:  2020-03-20       Impact factor: 2.872

5.  Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer Database.

Authors:  Nicholas J Farber; Zorimar Rivera-Núñez; Sinae Kim; Brian Shinder; Kushan Radadia; Joshua Sterling; Parth K Modi; Sharad Goyal; Rahul Parikh; Tina M Mayer; Robert E Weiss; Isaac Y Kim; Sammy E Elsamra; Thomas L Jang; Eric A Singer
Journal:  Urol Oncol       Date:  2018-11-13       Impact factor: 3.498

6.  Development of a framework to assess the quality of data sources in healthcare settings.

Authors:  Sepideh Hooshafza; Louise Mc Quaid; Gaye Stephens; Rachel Flynn; Laura O'Connor
Journal:  J Am Med Inform Assoc       Date:  2022-04-13       Impact factor: 4.497

7.  Patient Perspectives About Decisions to Share Medical Data and Biospecimens for Research.

Authors:  Jihoon Kim; Hyeoneui Kim; Elizabeth Bell; Tyler Bath; Paulina Paul; Anh Pham; Xiaoqian Jiang; Kai Zheng; Lucila Ohno-Machado
Journal:  JAMA Netw Open       Date:  2019-08-02

8.  Metabolic Syndrome and Risk of Upper Tract Urothelial Carcinoma: A Case-Control Study From Surveillance, Epidemiology and End Results-Medicare-Linked Database.

Authors:  Yi Lu; Wei Zhang; Shujun Fan; Zhen Liang; Zhongjia Li; Jia Tian; Jiaqi Kang; Yuxuan Song; Kang Liu; Kechong Zhou; Xiao Wang; Yongjiao Yang; Xiaoqiang Liu
Journal:  Front Oncol       Date:  2021-01-21       Impact factor: 6.244

9.  Association of Care at Minority-Serving vs Non-Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United States.

Authors:  Alexander P Cole; David-Dan Nguyen; Akezhan Meirkhanov; Mehra Golshan; Nelya Melnitchouk; Stuart R Lipsitz; Kerry L Kilbridge; Adam S Kibel; Zara Cooper; Joel Weissman; Quoc-Dien Trinh
Journal:  JAMA Netw Open       Date:  2019-02-01

Review 10.  Repurposing NGO data for better research outcomes: a scoping review of the use and secondary analysis of NGO data in health policy and systems research.

Authors:  Sarah C Masefield; Alice Megaw; Matt Barlow; Piran C L White; Henrice Altink; Jean Grugel
Journal:  Health Res Policy Syst       Date:  2020-06-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.